Payers, Providers, and Patients – Oh My!
By Crowell & Moring
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Crowell & Moring
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 40
Description
Crowell & Moring’s biweekly health care podcast, discussing legal and regulatory issues that affect health care entities’ in-house counsel, executives, and investors.
| Episode | Date |
|---|---|
|
The Past, Present, and Future of Private Equity’s Role in Health Care
|
Apr 09, 2024 |
|
Enabling Widespread Adoption of Decentralized Clinical Trials
|
Feb 23, 2024 |
|
The Increasing Focus on Mental Health Parity
|
Jan 25, 2024 |
|
Hidden Costs of FCA and AKS Claims
|
May 25, 2023 |
|
Industry Views on the Trusted Exchange Framework and Common Agreement
|
Apr 26, 2023 |
|
How to Structure an Affirmative Recovery Program
|
Feb 28, 2023 |
|
More Changes to Section 1557 Nondiscrimination Rules
|
Nov 30, 2022 |
|
The Shrinking Medical Loss Ratio Numerator
|
Aug 29, 2022 |
|
Massive Federal Investment in Mental Health
|
Jul 28, 2022 |
|
Crowell Health Solutions Mini-Series Part 2 – A Health System’s Perspective on Prioritizing Health Equity
|
Jun 21, 2022 |
|
Shared-Risk Arrangements in California
|
Jun 01, 2022 |
|
Crowell Health Solutions Mini-Series Part 1 - The Intersection of Technology and Value-Based Care
|
Apr 25, 2022 |
|
What to Expect in Healthcare Transactions in 2022
|
Mar 28, 2022 |
|
What Health Care Companies Should Know about Developments in FCA Litigation
|
Feb 28, 2022 |
|
Reflecting on the First Year of the 2020 Stark & AKS Regulations
|
Jan 14, 2022 |
|
The New World of Health Data Interoperability
|
Dec 08, 2021 |
|
How Health Plans Can Address Social Determinants of Health
|
Nov 22, 2021 |
|
Business and Clinical Considerations for the Ketamine Industry
|
Nov 22, 2021 |
|
Recent Mental Health Parity Enforcement Activities
|
Sep 22, 2021 |
|
The ACA Risk Corridors Case
|
Feb 22, 2021 |
|
Data Analytics and FCA Investigations
|
Jan 21, 2021 |
|
Rating in the Time of COVID
|
Dec 10, 2020 |
|
ERISA Preemption of State PBM Regulation
|
Aug 03, 2020 |
|
Bostock and HHS’s Nondiscrimination Regulations
|
Jun 29, 2020 |
|
Who CARES: The Provider Relief Fund and Other CARES Act Provisions
|
Jun 04, 2020 |
|
What Providers Should Know about COVID-19 (Part 2 – Federal and State Guidance)
|
Mar 26, 2020 |
|
What Providers Should Know about COVID-19 (Part 1 – Labor and Employment Issues)
|
Mar 26, 2020 |
|
Medical Loss Ratios (Part 2)
|
Mar 18, 2020 |
|
Medical Loss Ratios (Part 1)
|
Feb 25, 2020 |
|
Digital Health Innovation
|
Jan 14, 2020 |
|
Multi-State Plan Program
|
Dec 12, 2019 |
|
Pharmacy Benefit Managers
|
Nov 13, 2019 |
|
Payers, Providers, and Patients – Oh My!: FDA Digital Health Guidance
|
Oct 23, 2019 |
|
Medicare Advantage Supplemental Benefits
|
Oct 10, 2019 |
|
Removal under ERISA
|
Sep 11, 2019 |
|
Some Potential Impacts of Legal Challenges to the ACA
|
Aug 21, 2019 |
|
Health Care Compliance Programs
|
Aug 07, 2019 |
|
Private Equity Investing in Health Care
|
Jul 23, 2019 |
|
Fiduciary Duties Under ERISA
|
Jul 10, 2019 |
|
FCA Dismissals Under the Granston Memo
|
Jun 24, 2019 |